Search

everythinglearnresearchcommunity

for

Search:↓

Selaginella doederleinii extract shows potential for cervical cancer treatment but needs more research.

Patients with HR+/HER2- advanced breast cancer commonly experience fatigue, hair loss, and pain, which significantly affect daily activities.

Inhaling medicine may reduce side effects and improve treatment for a major lung cancer type.

Synthetic curcumin derivatives improve treatment for diabetes and cancer.

Enhancers and super-enhancers are key in controlling specific gene activity and can play a role in cancer development.

Targeting specific molecular pathways may improve treatments for chemoresistant cancers.

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.

Cinobufacin with chemotherapy improves treatment response and quality of life in advanced breast cancer patients while reducing some side effects.

New CRISPR/Cas9 variants and nanotechnology-based delivery methods are improving cancer treatment, but choosing the best variant and overcoming certain limitations remain challenges.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

Combining letrozole and quercetin in spanlastics may improve breast cancer treatment.

Adding celecoxib to chemotherapy improves survival and quality of life for gastric cancer patients with positive COX-2.

The hairless protein is important for skin, hair, and may influence cancer development.

A cancer drug caused unusual hair growth on a 100-year-old man's scalp and eyelashes.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Targeted cancer therapies often cause serious skin problems that need careful management.

Oral contraceptives provide various health benefits beyond birth control, including managing menstrual issues, skin conditions, pain, and reducing the risk of certain cancers.

Vitamin D and its receptor may help prevent skin cancer.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Early detection of specific skin lesions can help identify Birt-Hogg-Dube syndrome and prevent serious complications.

A mouse gene mutation increases the risk of skin cancer.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

PPAR β/δ is important for skin health and disease treatment, but more research is needed.

Rosemary may help treat various skin conditions due to its antioxidant and anti-inflammatory properties.

CCCA affects adolescents too, with genetic and environmental links, requiring careful diagnosis.

Epigenetic factors play a crucial role in skin health and disease.

Certain cancer drugs are strongly linked to nerve damage, requiring close monitoring and early treatment.

Olfactory receptors found outside the nose may offer new treatments for diseases like cancer and help in wound healing and hair growth.